Injective vs staked USD1+ Staking
Side-by-side comparison of INJ and SUSD1+ staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Injective vs staked USD1+: which should you stake?
Injective currently offers the higher APY at 6.52% compared to staked USD1+'s 4.00%. That's a 2.52 percentage point difference in annual yield.
In terms of market cap, Injective is the larger asset at $465.44M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Injective vs staked USD1+ — common questions
Is Injective or staked USD1+ better for staking?
Injective currently offers a higher staking APY at 6.52% compared to staked USD1+'s 4.00%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Injective and staked USD1+?
Injective offers 6.52% APY while staked USD1+ offers 4.00% APY — a difference of 2.52 percentage points.
Which is safer to stake: INJ or SUSD1+?
Injective has a medium risk rating while staked USD1+ has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both INJ and SUSD1+?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Injective and staked USD1+ spreads your risk across different networks and protocols.